Remove 2011 Remove Immunization Remove Vaccines
article thumbnail

Data hackathon analyses truth behind TB vaccine and COVID-19

pharmaphorum

Is a century-old vaccine a ‘game-changer’ for COVID-19? This is especially true in the search for effective therapies to fight COVID-19, and a vaccine. In a worst-case scenario, misplaced hype could lead to a sudden rush to buy doses of the BCG vaccine. Understanding the link between COVID-19 and the BCG vaccine.

Vaccines 110
article thumbnail

Phase 3 trial data confirm efficacy and safety profile of R21/Matrix-M malaria vaccine in African children

Express Pharma

Phase 3 trial data results of The R21/Matrix-M vaccine developed by Oxford University and Serum Institute of India, leveraging Novavax’s Matrix-M adjuvant has confirmed high efficacy and supported regulatory approvals and licensure in several African countries. No other vaccine has reported over 55 per cent efficacy in the same age group.

Vaccines 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Investment fuels AI-driven development of breakthrough genomic medicines

pharmaphorum

Del Bourgo highlights that genomic treatments work in a similar way to mRNA, which has been used in COVID-19 vaccines. Similar to how we injected mRNA into people to trigger an immune response and train their immune system against COVID-19, genomic medicine repairs cellular or molecular mechanisms that are dysfunctional and cause disease.”.

article thumbnail

Health Innovation Fund, Moderna’s largest shareholder, shares investment strategies

pharmaphorum

“Effectively, they create antibodies that can train one’s immune system to go after a specific cancer cell. ” Moderna has also created a personalised cancer vaccine, a similar idea where the vaccine is built against the specific cancer one has in the body. It could completely change how we treat cancers.”

Vaccines 102
article thumbnail

Paving the way for anti-Abeta active immunotherapy

European Pharmaceutical Review

Active anti-Abeta immunotherapies In the 2000s, the concept of active immunotherapy targeting Abeta in Alzheimer’s patients was assessed with the ELAN vaccine (AN1792), consisting of full-length aggregated Abeta 1-42 peptide mixed with the QS21 adjuvant. 8 However, as this trial was not placebo-controlled, conclusions are difficult to draw.

article thumbnail

Cracking the code – Generic vs. Brand Medicines

Express Pharma

Karnataka Antibiotics, and Bengal Immunity, etc. 1 Currently, as per a study done by Competition Commission of India, it was revealed that during 2011-2012, 47,478 brands were available with 2,871 formulations marketed in India, with an average of 17 brands for every formulation. 318 crores. 3,810 crores were introduced.

article thumbnail

Common Hashimoto’s Patterns Seen in the GI-MAP Test

The Thyroid Pharmacist

It is a comprehensive stool-based test that addresses a wide range of microbial targets (bacteria, opportunistic organisms, viruses, parasites, fungi, and normal flora), as well as immune and digestive markers. This can allow the body’s immune system to attack the thyroid (or elsewhere) versus the infection. [17]